Differential expression of genes encoding neuronal ion-channel subunits in major depression, bipolar disorder and schizophrenia: Implications for pathophysiology

International Journal of Neuropsychopharmacology

Volumn 15, Issue 7, 2012, Pages 869-882

  Smolin, Bella ^a   Karry, Rachel ^b   Gal Ben Ari, Shunit ^b   Ben Shachar, Dorit ^b  

^a RAMBAM MEDICAL CENTER   (Israel)

^b TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

Bipolar disorder; human post mortem brain specimens; ion channel gene expression; major depression; schizophrenia

Indexed keywords

ALPRAZOLAM; AMFEBUTAMONE; AMITRIPTYLINE; BENZATROPINE; BUSPIRONE; CARBAMAZEPINE; CHLORPROTHIXENE; CLOMIPRAMINE; CLONAZEPAM; DIPHENHYDRAMINE; FLUOXETINE; FLURAZEPAM; HALOPERIDOL; HYDROXYZINE; IMIPRAMINE; ION CHANNEL; LITHIUM; LORAZEPAM; MESSENGER RNA; NEFAZODONE; NORTRIPTYLINE; PHENYTOIN; SERTRALINE; TEMAZEPAM; TIOTIXENE; TRIHEXYPHENIDYL; TRIMIPRAMINE; UNINDEXED DRUG; VALPROIC ACID; VENLAFAXINE;

ADULT; ARTICLE; BIPOLAR DISORDER; CEREBELLUM; CONTROLLED STUDY; CORPUS STRIATUM; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; LEFT HEMISPHERE; MAJOR DEPRESSION; MALE; MOLECULAR PATHOLOGY; NUCLEUS ACCUMBENS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PSYCHOPHARMACOTHERAPY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCHIZOPHRENIA; SEIZURE;

ADULT; ANALYSIS OF VARIANCE; ANTIDEPRESSIVE AGENTS; ANTIPSYCHOTIC AGENTS; BIPOLAR DISORDER; CHLORIDE CHANNELS; DEPRESSIVE DISORDER, MAJOR; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMANS; ION CHANNELS; MALE; MIDDLE AGED; NEURONS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; POTASSIUM CHANNELS, VOLTAGE-GATED; RNA, MESSENGER; SCHIZOPHRENIA; SODIUM CHANNELS;

EID: 84864364607     PISSN: 14611457     EISSN: 14695111     Source Type: Journal    
DOI: 10.1017/S1461145711001428     Document Type: Article

References (67)

1. Abler B, Greenhouse I, Ongur D, Walter H, et al. (2008). Abnormal reward system activation in mania. Neuropsychopharmacology 33, 2217-2227. (Pubitemid 351992090)
2. Amann B, Grunze H (2005). Neurochemical underpinnings in bipolar disorder and epilepsy. Epilepsia 46 (Suppl. 4), 26-30. (Pubitemid 40847380)
3. Andreasen NC, Pierson R (2008). The role of the cerebellum in schizophrenia. Biological Psychiatry 64, 81-88.
4. Aouizerate B, Cuny E, Martin-Guehl C, Guehl D, et al. (2004). Deep brain stimulation of the ventral caudate nucleus in the treatment of obsessive-compulsive disorder and major depression. case report. Journal of Neurosurgery 101, 682-686. (Pubitemid 43186430)
5. Baumann B, Danos P, Krell D, Diekmann S, et al. (1999). Reduced volume of limbic system-affiliated basal ganglia in mood disorders : preliminary data from a postmortem study. Journal of Neuropsychiatry and Clinical Neuroscience 11, 71-78. (Pubitemid 29070667)
6. Ben-Shachar D, Karry R (2007). Sp1 expression is disrupted in schizophrenia; a possible mechanism for the abnormal expression of mitochondrial complex I genes, NDUFV1 and NDUFV2. PLoS One 2, e817.
7. Ben-Shachar D, Karry R (2008). Neuroanatomical pattern of mitochondrial complex I pathology varies between schizophrenia, bipolar disorder and major depression. PLoS One 3, e3676.
8. Bewernick BH, Hurlemann R, Matusch A, Kayser S, et al. (2010). Nucleus accumbens deep brain stimulation decreases ratings of depression and anxiety in treatment-resistant depression. Biological Psychiatry 67, 110-116.
9. Bortolatto CF, Jesse CR, Wilhelm EA, Nogueira CW (2010). Involvement of potassium channels in the antidepressant-like effect of venlafaxine in mice. Life Sciences 86, 372-376.
10. Calderone V, Testai L, Martinotti E, Del Tacca M, et al. (2005). Drug-induced block of cardiac HERG potassium channels and development of torsade de pointes arrhythmias: the case of antipsychotics. Journal of Pharmacy and Pharmacology 57, 151-161. (Pubitemid 40129081)
11. Carlezon WA, Thomas MJ (2009). Biological substrates of reward and aversion : a nucleus accumbens activity hypothesis. Neuropharmacology 56 (Suppl. 1), 122-132.
12. Catterall WA, Dib-Hajj S, Meisler MH, Pietrobon D (2008). Inherited neuronal ion channelopathies : new windows on complex neurological diseases. Journal of Neuroscience 28, 11768-11777.
13. Coryell MW, Wunsch AM, Haenfler JM, Allen JE, et al. (2009). Acid-sensing ion channel-1a in the amygdala, a novel therapeutic target in depression-related behavior. Journal of Neuroscience 29, 5381-5388.
14. Crespo-Facorro B, Paradiso S, Andreasen NC, O'Leary DS, et al. (1999). Recalling word lists reveals 'cognitive dysmetria' in schizophrenia : a positron emission tomography study. American Journal of Psychiatry 156, 386-392. (Pubitemid 29124159)
15. Crespo-Facorro B, Paradiso S, Andreasen NC, O'Leary DS, et al. (2001). Neural mechanisms of anhedonia in schizophrenia : a PET study of response to unpleasant and pleasant odors. Journal of the American Medical Association 286, 427-435. (Pubitemid 32681485)
16. Dichter MA (1998). Mechanisms of action of new antiepileptic drugs. Advances in Neurology 76, 1-9.
17. Dror N, Klein E, Karry R, Sheinkman A, et al. (2002). State-dependent alterations in mitochondrial complex I activity in platelets : a potential peripheral marker for schizophrenia. Molecular Psychiatry 7, 995-1001. (Pubitemid 35333055)
18. Dror V, Shamir E, Ghanshani S, Kimhi R, et al. (1999). hKCa3/KCNN3 potassium channel gene: association of longer CAG repeats with schizophrenia in Israeli Ashkenazi Jews, expression in human tissues and localization to chromosome 1q21. Molecular Psychiatry 4, 254-260. (Pubitemid 29292175)
19. Duncan CE, Chetcuti AF, Schofield PR (2008). Coregulation of genes in the mouse brain following treatment with clozapine, haloperidol, or olanzapine implicates altered potassium channel subunit expression in the mechanism of antipsychotic drug action. Psychiatric Genetics 18, 226-239.
20. Duncan CE, Schofield PR, Weickert CS (2009). K(v) channel interacting protein 3 expression and regulation by haloperidol in midbrain dopaminergic neurons. Brain Research 1304, 1-13.
21. Elliott R, Sahakian BJ, Michael A, Paykel ES, et al. (1998). Abnormal neural response to feedback on planning and guessing tasks in patients with unipolar depression. Psychological Medicine 28, 559-571. (Pubitemid 28241289)
22. Epstein J, Pan H, Kocsis JH, Yang Y, et al. (2006). Lack of ventral striatal response to positive stimuli in depressed vs. normal subjects. American Journal of Psychiatry 163, 1784-1790. (Pubitemid 44522488)
23. Falk T, Xie JY, Zhang S, Kennedy J, et al. (2008). Over-expression of the potassium channel Kir2.3 using the dopamine-1 receptor promoter selectively inhibits striatal neurons. Neuroscience 155, 114-127.
24. Ferreira MA, O'Donovan MC, Meng YA, Jones IR, et al. (2008). Collaborative genome-wide association analysis supports a role for ANK3 and CACNA1C in bipolar disorder. Nature Genetics 40, 1056-1058.
25. Glatt SJ, Faraone SV, Tsuang MT (2003). CAG-repeat length in exon 1 of KCNN3 does not influence risk for schizophrenia or bipolar disorder : a meta-analysis of association studies. American Journal of Medical Genetics. Part B: Neuropsychiatric Genetics 121B, 14-20. (Pubitemid 37064024)
26. Green EK, Grozeva D, Jones I, Jones L, et al. (2010). The bipolar disorder risk allele at CACNA1C also confers risk of recurrent major depression and of schizophrenia. Molecular Psychiatry 15, 1016-1022.
27. Grube S, Gerchen MF, Adamcio B, Pardo LA, et al. (2011). A CAG repeat polymorphism of KCNN3 predicts SK3 channel function and cognitive performance in schizophrenia. EMBO Molecular Medicine 3, 309-319.
28. Higgs BW, Elashoff M, Richman S, Barci B (2006). An online database for brain disease research. BMC Genomics 7, 70.
29. Hjaeresen ML, Hageman I, Wortwein G, Plenge P, et al. (2008). Chronic electroconvulsive stimulation but not chronic restraint stress modulates mRNA expression of voltage-dependent potassium channels kv7.2 and kv11.1 in the rat piriform cortex. Brain Research 1217, 179-184.
30. Hong HK, Park MH, Lee BH, Jo SH (2010). Block of the human ether-a-go-go-related gene (hERG) K+ channel by the antidepressant desipramine. Biochemical and Biophysical Research Communication 394, 536-541.
31. Huffaker SJ, Chen J, Nicodemus KK, Sambataro F, et al. (2009). A primate-specific, brain isoform of KCNH2 affects cortical physiology, cognition, neuronal repolarization and risk of schizophrenia. Nature Medicine 15, 509-518.
32. Ichimiya T, Okubo Y, Suhara T, Sudo Y (2001). Reduced volume of the cerebellar vermis in neuroleptic-naive schizophrenia. Biological Psychiatry 49, 20-27. (Pubitemid 32332950)
33. + channel-deficient mice have enhanced dopamine and serotonin release and altered emotional behaviors. Genes Brain and Behavior 7, 836-848.
34. Keedwell PA, Andrew C, Williams SC, Brammer MJ, et al. (2005). The neural correlates of anhedonia in major depressive disorder. Biological Psychiatry 58, 843-853. (Pubitemid 41790711)
35. Kennard LE, Chumbley JR, Ranatunga KM, Armstrong SJ, et al. (2005). Inhibition of the human two-pore domain potassium channel, TREK-1, by fluoxetine and its metabolite norfluoxetine. British Journal of Pharmacology 144, 821-829. (Pubitemid 40516121)
36. Ketter TA, Kimbrell TA, George MS, Dunn RT, et al. (2001). Effects of mood and subtype on cerebral glucose metabolism in treatment-resistant bipolar disorder. Biological Psychiatry 49, 97-109. (Pubitemid 32119503)
37. Liou YJ, Chen TJ, Tsai SJ, Yu YW, et al. (2009). Support for the involvement of the KCNK2 gene in major depressive disorder and response to antidepressant treatment. Pharmacogenetics and Genomics 19, 735-741.
38. Lodge NJ, Li YW (2008). Ion channels as potential targets for the treatment of depression. Current Opinions in Drug Discovery and Development 11, 633-641.
39. Malhi GS, Lagopoulos J, Owen AM, Ivanovski B, et al. (2007). Reduced activation to implicit affect induction in euthymic bipolar patients : an fMRI study. Journal of Affective Disorders 97, 109-122. (Pubitemid 44937425)
40. Mazza M, Di Nicola M, Della Marca G, Janiri L, et al. (2007). Bipolar disorder and epilepsy: a bidirectional relation? Neurobiological underpinnings, current hypotheses, and future research directions. Neuroscientist 13, 392-404. (Pubitemid 47062982)
41. McGowan PO, Meaney MJ, Szyf M (2008). Diet and the epigenetic (re)programming of phenotypic differences in behavior. Brain Research 1237, 12-24.
42. McIlwrath SL, Hu J, Anirudhan G, Shin JB, et al. (2005). The sensory mechanotransduction ion channel ASIC2 (acid sensitive ion channel 2) is regulated by neurotrophin availability. Neuroscience 131, 499-511. (Pubitemid 40222457)
43. + channels in NMDA receptor-independent synaptic plasticity and spatial memory. Journal of Neuroscience 25, 9883-9892. (Pubitemid 41528025)
44. Moskvina V, Craddock N, Holmans P, Nikolov I, et al. (2009). Gene-wide analyses of genome-wide association data sets : evidence for multiple common risk alleles for schizophrenia and bipolar disorder and for overlap in genetic risk. Molecular Psychiatry 14, 252-260.
45. Namaka M, Gramlich CR, Ruhlen D, Melanson M, et al. (2004). A treatment algorithm for neuropathic pain. Clinical Therapeutics 26, 951-979. (Pubitemid 39141802)
46. Nestler EJ, Carlezon WA (2006). The mesolimbic dopamine reward circuit in depression. Biological Psychiatry 59, 1151-1159. (Pubitemid 44192421)
47. +) channels by antidepressant drugs. European Journal of Pharmacology 452, 35-48. (Pubitemid 35248122)
48. Nopoulos PC, Ceilley JW, Gailis EA, Andreasen NC (1999). An MRI study of cerebellar vermis morphology in patients with schizophrenia : evidence in support of the cognitive dysmetria concept. Biological Psychiatry 46, 703-711. (Pubitemid 29401867)
49. O'Donovan MC, Craddock NJ, Owen MJ (2009). Genetics of psychosis; insights from views across the genome. Human Genetics 126, 3-12.
50. Ohno Y, Hibino H, Lossin C, Inanobe A, et al. (2007). Inhibition of astroglial Kir4.1 channels by selective serotonin reuptake inhibitors. Brain Research 1178, 44-51. (Pubitemid 47625356)
51. + channels by antidepressant drugs. Journal of Pharmacology and Experimental Therapeutics 284, 208-214. (Pubitemid 28109548)
52. Peng J, Liu J, Nie B, Li Y, et al. (2010). Cerebral and cerebellar gray matter reduction in first-episode patients with major depressive disorder : a voxel-based morphometry study. European Journal of Radiology.
53. Pizzagalli DA (2010). The 'anhedonia paradox' in schizophrenia : insights from affective neuroscience. Biological Psychiatry 67, 899-901.
54. Pizzagalli DA, Holmes AJ, Dillon DG, Goetz EL, et al. (2009). Reduced caudate and nucleus accumbens response to rewards in unmedicated individuals with major depressive disorder. American Journal of Psychiatry 166, 702-710.
55. Pruss, H, Wenzel M, Eulitz D, Thomzig A, et al. (2003). Kir2 potassium channels in rat striatum are strategically localized to control basal ganglia function. Brain Research. Molecular Brain Research 110, 203-219. (Pubitemid 36184694)
56. Rapoport M, van Reekum R, Mayberg H (2000). The role of the cerebellum in cognition and behavior: a selective review. Journal of Neuropsychiatry and Clinical Neuroscience 12, 193-198. (Pubitemid 30303773)
57. Rimol LM, Hartberg CB, Nesvag R, Fennema-Notestine C, et al. (2010). Cortical thickness and subcortical volumes in schizophrenia and bipolar disorder. Biological Psychiatry 68, 41-50.
58. Roberts JD, Gollob MH (2010). The genetic and clinical features of cardiac channelopathies. Future Cardiology 6, 491-506.
59. Schmahmann JD (2004). Disorders of the cerebellum: ataxia, dysmetria of thought, and the cerebellar cognitive affective syndrome. Journal of Neuropsychiatry and Clinical Neuroscience 16, 367-378. (Pubitemid 39244566)
60. Smoski MJ, Felder J, Bizzell J, Green SR, et al. (2009). fMRI of alterations in reward selection, anticipation, and feedback in major depressive disorder. Journal of Affective Disorders 118, 69-78.
61. Steele JD, Kumar P, Ebmeier KP (2007). Blunted response to feedback information in depressive illness. Brain 130, 2367-2374. (Pubitemid 47327628)
62. Strakowski SM, Adler CM, Holland SK, Mills NP, et al. (2005). Abnormal FMRI brain activation in euthymic bipolar disorder patients during a counting stroop interference task. American Journal of Psychiatry 162, 1697-1705. (Pubitemid 41318240)
63. Tomita H, Shakkottai VG, Gutman GA, Sun G, et al. (2003). Novel truncated isoform of SK3 potassium channel is a potent dominant-negative regulator of SK currents : implications in schizophrenia. Molecular Psychiatry 8, 524-535. (Pubitemid 36829694)
64. Torrey EF, Webster M, Knable M, Johnston N, et al. (2000). The Stanley foundation brain collection and neuropathology consortium. Schizophrenia Research 44, 151-155. (Pubitemid 30411930)
65. Wassink TH, Andreasen NC, Nopoulos P, Flaum M (1999). Cerebellar morphology as a predictor of symptom and psychosocial outcome in schizophrenia. Biological Psychiatry 45, 41-48. (Pubitemid 29049203)
66. Wolfart J, Neuhoff H, Franz O, Roeper J (2001). Differential expression of the small-conductance, calcium-activated potassium channel SK3 is critical for pacemaker control in dopaminergic midbrain neurons. Journal of Neuroscience 21, 3443-3456. (Pubitemid 32422809)
67. Yeung SY, Millar JA, Mathie A (1999). Inhibition of neuronal KV potassium currents by the antidepressant drug, fluoxetine. British Journal of Pharmacology 128, 1609-1615.